Evidence map›Paper›PMID 34361740›Full record

ReviewMolecules (Basel, Switzerland)2021

Synthesis, Characterization and Evaluation of Peptide Nanostructures for Biomedical Applications.

Fanny d'Orlyé, Laura Trapiella-Alfonso, Camille Lescot, Marie Pinvidic, Bich-Thuy Doan, Anne Varenne

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fanny d'OrlyéChimie ParisTech PSL, CNRS 8060, Institute of Chemistry for Life and Health (i-CLeHS), 75005 Paris, France.
Laura Trapiella-AlfonsoChimie ParisTech PSL, CNRS 8060, Institute of Chemistry for Life and Health (i-CLeHS), 75005 Paris, France.ORCID 0000-0002-8768-9087
Camille LescotChimie ParisTech PSL, CNRS 8060, Institute of Chemistry for Life and Health (i-CLeHS), 75005 Paris, France.
Marie PinvidicChimie ParisTech PSL, CNRS 8060, Institute of Chemistry for Life and Health (i-CLeHS), 75005 Paris, France.
Bich-Thuy DoanChimie ParisTech PSL, CNRS 8060, Institute of Chemistry for Life and Health (i-CLeHS), 75005 Paris, France.
Anne VarenneChimie ParisTech PSL, CNRS 8060, Institute of Chemistry for Life and Health (i-CLeHS), 75005 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a challenging need for the development of new alternative nanostructures that can allow the coupling and/or encapsulation of therapeutic/diagnostic molecules while reducing their toxicity and improving their circulation and in-vivo targeting. Among the new materials using natural building blocks, peptides have attracted significant interest because of their simple structure, relative chemical and physical stability, diversity of sequences and forms, their easy functionalization with (bio)molecules and the possibility of synthesizing them in large quantities. A number of them have the ability to self-assemble into nanotubes, -spheres, -vesicles or -rods under mild conditions, which opens up new applications in biology and nanomedicine due to their intrinsic biocompatibility and biodegradability as well as their surface chemical reactivity via amino- and carboxyl groups. In order to obtain nanostructures suitable for biomedical applications, the structure, size, shape and surface chemistry of these nanoplatforms must be optimized. These properties depend directly on the nature and sequence of the amino acids that constitute them. It is therefore essential to control the order in which the amino acids are introduced during the synthesis of short peptide chains and to evaluate their in-vitro and in-vivo physico-chemical properties before testing them for biomedical applications. This review therefore focuses on the synthesis, functionalization and characterization of peptide sequences that can self-assemble to form nanostructures. The synthesis in batch or with new continuous flow and microflow techniques will be described and compared in terms of amino acids sequence, purification processes, functionalization or encapsulation of targeting ligands, imaging probes as well as therapeutic molecules. Their chemical and biological characterization will be presented to evaluate their purity, toxicity, biocompatibility and biodistribution, and some therapeutic properties in vitro and in vivo. Finally, their main applications in the biomedical field will be presented so as to highlight their importance and advantages over classical nanostructures.

Indexed as

Amino Acid SequenceAnimalsBiocompatible MaterialsDrug CarriersDrug CompoundingHumansNanostructuresParticle SizePeptidesSolid-Phase Synthesis TechniquesTissue DistributionBiocompatible MaterialsDrug CarriersPeptidesbiomedical applicationsflow chemistrynanotheranosticspeptide self-assemblypeptide synthesisphysicochemical and biological characterization

Identifiers

PMID34361740
PMCPMC8348434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.